[1] 蒙诗景, 杨小勇. 血液透析动静脉内瘘的临床进展[J]. 医学文摘, 2012,27(4):357-358.
[2] 叶朝阳. 中心静脉长期留置导管面临的几个重要问题[J]. 临床肾脏病杂志, 2012,7.12(7):292-294.
[3] Chan M R.Hemodialysis central venous catheter dysfunction[J]. Semin Dial, 2008, 21(6):516-521.
[4] 李春兰,周怡,谢培杰. 长期留置双腔导管在血液透析中的应用进展[J]. 中华现代护理杂志, 2013,19(34):4214-4216.
[5] 崔文鹏,杜冰,周文华,等.血液透析患者中心静脉导管纯肝素封管可行性的系统评价[J]. 中国血液净化, 2011,2,10(2):67-70.
[6] Alexander S, Yevzlin, Robert J, et al. Concentrated Helparin Lock Is Associated with major bleeding complications after tunneled hemodialysis catheter placement[J]. Semin Dial, 2007,20(4):351-354.
[7] Thomson P C, Morris S T, Mactier R A.The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients[J].Clinical Nephrology, 2011.75(3):212-217.
[8] Hu H H, Hsu C Y, Fang H C, et al. Low—dose heparin retention in temporary hemodialysis double— lumen catheter does not increase catheter occlusion and might reduce risk of bleeding[J].Blood Purif, 2011,32(3):232-237.
[9] 吕美,杨冰,李艳玲,等. 肝素封管后短时间内对全身凝血机制的影响[J]. 中国血液净化, 2016,2,15(2):86-90.
[10] Ruth J, PEPPER, Daniel P, et al.Inadvertent postdialysis anticoagulation due to heparin 1ine locks[J].Hemodialysis International, 2007,11:430-434.
[11] Ivan D, Maya, Tamorie Smith,et al.Does the heparin lock concentration affect hemodialysis catheter patency[J]. C1in J Am Soe Nephrol, 2010,5:1458-1462.
[12] 纪春芬. 不同浓度肝素在血液透析中心静脉导管封管中应用效果[J].中国临床护理, 2016,5,8(3):218-220.
[13] Bevilacqua J L, Gomes J G, Santos V F, et al. Comparison of trisodium citrate and heparin as catheter-locking solution in hemodialysis patients[J].J Bras Nefrol, 2011,33(1):86-92.
[14] Ash S R, Mankus R A, Sutton J M, et al.C0ncentrated sodium citrate(23%)for catheter 10ck[J].Hemodial Int, 2000,4:22-31.
[15] Yon C K, Low C L.Sodium citrate 4%versus heparin as a 10ck solution in hemodialysis patients with central venous catheters[J].Am J Health Syst Pharm, 2013,70:13-136.
[16] Grudzinski L, Quinan P, Kwok s, et al.Sodium citrate4% locking solution for central venous dialysis catheters an effective.more cost efficient alternative to heparin[J]. Nephr01 Dial Transplant, 2007,22(2):471-475.
[17] 薛志强, 曾石养.尿激酶24小时停留封管溶栓治疗对颈内静脉留置双腔透析导管内血栓形成的疗效研究[J].中国血液净化, 2010,9(5):265-268.
[18] 叶朝阳,张玉强,张黎明,等. 190例次涤纶环深静脉留置导管应用回顾性分析[J]. 中国血液净化, 2005,4(3):142-145.
[19] 董建华, 邓学杰, 董艳,等.血液透析半永久导管3中封管方法比较[J].中国社区医师, 2016,32(19):81-82.
[20] 任月运,李红梅. 定期尿激酶联合肝素封管对预防血液透析长期导管感染的观察[J]. 中国血液净化, 2016,6,15(6):341-343.
[21] 韩丽丽,孙静,陈雅慧,等. 脉冲式封管联合正压封管在半永久置管中的效果观察[J]. 河北医科大学学报, 2016,5,37(5):589-591.
[22] 梁红丽,杨娟,莫世松,等. 按管腔容积80%封管在血透长期导管中的临床应用[J]. 海南医学,2016,5,27(9):1547-1548.
[23] 叶朝阳. 中心静脉长期留置导管面临的几个重要问题[J].临床肾病脏病杂志, 2012,12(7):292-294.